Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis
Letizia Crocetti, Claudia Vergelli, Gabriella Guerrini, Niccolò Cantini, Liliya N. Kirpotina, Igor A. Schepetkin, Mark T. Quinn, Carmen Parisio, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Maria Paola Giovannoni
Topics & Concepts
ChemistryAgonistIn vivoRheumatoid arthritisAcetamidePharmacologyReceptorTherapeutic indexArthritisStereochemistryPartial agonistEC50Biological activityCombinatorial chemistryIn vitroBiochemistryDrugImmunologyMedicineOrganic chemistryBiologyBiotechnologyS100 Proteins and AnnexinsBiomarkers in Disease MechanismsBlood Coagulation and Thrombosis Mechanisms